Great Diamond Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Great Diamond Partners, LLC

$457 Million
Q2 2025

A detailed history of Great Diamond Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Great Diamond Partners, LLC holds 1,776 shares of VRTX stock, worth $726,117. This represents 0.17% of its overall portfolio holdings.

Number of Shares

1,776

Previous 1,353 31.26%

Holding current value

$726,117

Previous $655,000 20.61%

% of portfolio

0.17%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$421.16 - $509.5 $178,150 - $215,518	423 Added 31.26%	1,776 $790,000
Q1 2025 May 13, 2025	BUY	$402.49 - $513.76 $136,041 - $173,650	338 Added 33.3%	1,353 $655,000
Q4 2024 Jan 23, 2025	SELL	$396.64 - $516.74 $4,759 - $6,200	-12 Reduced 1.17%	1,015 $408,000
Q3 2024 Oct 25, 2024	SELL	$460.0 - $505.78 $313,720 - $344,941	-682 Reduced 39.91%	1,027 $477,000
Q2 2024 Jul 29, 2024	SELL	$392.81 - $485.53 $13,355 - $16,508	-34 Reduced 1.95%	1,709 $801,000
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $6,523 - $7,137	-16 Reduced 0.91%	1,743 $728,000
Q4 2023 Feb 07, 2024	BUY	$343.0 - $410.68 $7,203 - $8,624	21 Added 1.21%	1,759 $715,000
Q3 2023 Oct 19, 2023	BUY	$338.18 - $362.46 $338 - $362	1 Added 0.06%	1,738 $604,000
Q2 2023 Jul 17, 2023	BUY	$314.42 - $351.91 $43,704 - $48,915	139 Added 8.7%	1,737 $611,000
Q1 2023 May 04, 2023	SELL	$283.23 - $323.1 $57,495 - $65,589	-203 Reduced 11.27%	1,598 $503,000
Q4 2022 Feb 01, 2023	SELL	$285.76 - $321.48 $33,148 - $37,291	-116 Reduced 6.05%	1,801 $520,000
Q3 2022 Oct 24, 2022	SELL	$273.83 - $305.53 $22,727 - $25,358	-83 Reduced 4.15%	1,917 $555,000
Q2 2022 Jul 26, 2022	SELL	$234.96 - $292.55 $113,485 - $141,301	-483 Reduced 19.45%	2,000 $563,000
Q1 2022 May 05, 2022	SELL	$221.42 - $260.97 $33,877 - $39,928	-153 Reduced 5.8%	2,483 $647,000
Q4 2021 Jan 26, 2022	SELL	$177.01 - $223.45 $6,726 - $8,491	-38 Reduced 1.42%	2,636 $578,000
Q3 2021 Oct 21, 2021	BUY	$181.39 - $202.99 $485,036 - $542,795	2,674 New	2,674 $485,000
Q1 2020 May 01, 2020	SELL	$199.77 - $247.81 $6,792 - $8,425	-34 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$166.71 - $223.91 $5,668 - $7,612	34 New	34 $7,000

Others Institutions Holding VRTX

# of Institutions

1,809

Shares Held

239M

Call Options Held

1.95M

Put Options Held

1.14M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.

Account

Great Diamond Partners, LLC Vertex Pharmaceuticals Inc Transaction History